CFMS News and Press, Conformis Inc. From 08/17/21

These 3 Biotech Penny Stocks Could Be Worth Looking Into Over the past year and a half, biotech penny stocks have remained some of the hottest small caps for investors of all types. And, there are a few reasons why this is the case. First and foremost, biotech penny stocks present a...

ConforMIS (NASDAQ:CFMS): Q2 GAAP EPS of $0.21 beats by $0.18. Revenue of $56.3M (+189.2% Y/Y) beats by $23.3M. Shares -4.5%. Press Release For further details see: ConforMIS EPS beats by $0.18, beats on revenue

BILLERICA, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2021. Second Quarter 202...

BeyondSpring BYSI +336% Positive Topline Results from its DUBLIN-3 Registrational Trial of Plinabulin in Combination with Docetaxel for the Treatment of 2nd/3rd Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Wild Type Wheeler Real Estate  (NASDAQ:WHLR) +18%. Robinhood Market...

3 Penny Stocks to Watch For the First Week of August With another month of penny stocks trading here, investors are excited to get off to a fresh start. While July had its positive momentum, the month overall was quite volatile. During July, we saw the S&P 500 take major dives, foll...

Are These Penny Stocks Worth Adding to Your August Watchlist? With a new month of penny stocks trading only a week or so away, which companies are investors watching? Well, to understand this, we have to understand the current market conditions and which penny stocks could benefit. ...

The rising demand for advanced medical devices with the increasing focus on treating ailments other than COVID-19 bodes wells for Integer Holdings (ITGR) and Conformis (CFMS). But which of these two stocks is a better buy now? Read more to find out. Integer Holdings Corporation ( ITGR ...

Socket Mobile SCKT +79% on Q2 earningsAlzamend Neuro ALZN +62% after data showing safety of Alzheimer’s therapy in mouse studyVeoneer VNE +55% on earningsAcorda Therapeutics ACOR+49% on INBRIJA distribution and supply dealNRx Pharmaceuticals (NRXP) +5...

NeuroBo Pharmaceuticals (NRBO) +36%.Immunome (IMNM) +29% rallies 31% after antibody cocktail neutralizes Delta variant in pre-clinical testingMediWound (MDWD) +19% announces positive topline results from Phase 3 pediatric ctudy (CIDS) of nexoBrid for eschar removal of seve...

NRx Pharmaceuticals (NRXP) +68% shares jump 12% as Zyesami helps prevent cytokine storm in COVID-19Cytokinetics (CYTK) +47% shares soar on results from mid-stage cardiomyopathy trial cohortsSPX FLOW (FLOW) +27% Ingersoll Rand makes $85/share bid to buy SPX FlowAe...